Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - doxycycline hydrochloride 114mg (as docyclycine hyclate = doxycycline 100mg);   - tablet - 100 mg - active: doxycycline hydrochloride 114mg (as docyclycine hyclate = doxycycline 100mg)   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - doxycycline hydrochloride 57mg (as docyclycine hyclate = doxycycline 50mg);   - tablet - 50 mg - active: doxycycline hydrochloride 57mg (as docyclycine hyclate = doxycycline 50mg)   excipient: colloidal silicon dioxide magnesium stearate maize starch microcrystalline cellulose opadry white y-1r-7000b

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluconazole 150mg - capsule - 150 mg - active: fluconazole 150mg excipient: ammonia solution butyl alcohol colloidal silicon dioxide ethanol gelatin   iron oxide black isopropyl alcohol lactose monohydrate magnesium stearate maize starch patent blue v   potassium hydroxide propylene glycol purified water   shellac sodium laurilsulfate titanium dioxide   water - ozole 150 mg capsule, given orally, is indicated for vaginal candidiasis.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluconazole 200mg - capsule - 200 mg - active: fluconazole 200mg excipient: ammonia solution butyl alcohol colloidal silicon dioxide erythrosine ethanol gelatin   iron oxide black isopropyl alcohol lactose monohydrate magnesium stearate maize starch patent blue v potassium hydroxide propylene glycol purified water   shellac sodium laurilsulfate titanium dioxide   water - ozole is indicated for the treatment of the following conditions: 1. cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. ozole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids. 2. systemic candidiasis including candidaemia, disseninated candidasis and other forms of invasive candidal infection, including infections of the peritoneum, endocardium and pulmonary and urinary tracts. patients with malignancy, in intensive care units, receiving cytotoxic or immunosuppressive therapy, or with other factors predisposing to candidal infection may be treated. 3. mucosal candidiasis. these include oropharyngeal, oesophageal, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis (denture sore mouth). normal hosts and patients with compromised immune function may be treated. 4. vaginal candidiasis, acute or recurrent. 5. prevention of fungal infection in immunocompromised patients considered at risk as a consequence of hiv infections or neutropenia following cytoxic chemotherapy, radiotherapy or bone marrow transplant. 6. ozole 50 mg and 150 mg capsules are also indicated for the treatment of dermatomycoses including tinea pedis, tinea corporis, tinea cruris, pityriasis versicolor & candidiasis.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - fluconazole 50mg - capsule - 50 mg - active: fluconazole 50mg excipient: ammonia solution butyl alcohol colloidal silicon dioxide ethanol gelatin   iron oxide black isopropyl alcohol lactose monohydrate magnesium stearate maize starch patent blue v potassium hydroxide propylene glycol purified water   shellac sodium laurilsulfate titanium dioxide   water - ozole is indicated for the treatment of the following conditions: 1. cryptococcosis, including cryptococcal meningitis and infections of other sites (e.g. pulmonary cutaneous). normal hosts, and patients with aids, organ transplants or other causes of immunosuppression may be treated. ozole can be used as maintenance therapy to prevent relapse of cryptococcal disease in patients with aids. 2. systemic candidiasis including candidaemia, disseninated candidasis and other forms of invasive candidal infection, including infections of the peritoneum, endocardium and pulmonary and urinary tracts. patients with malignancy, in intensive care units, receiving cytotoxic or immunosuppressive therapy, or with other factors predisposing to candidal infection may be treated. 3. mucosal candidiasis. these include oropharyngeal, oesophageal, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis (denture sore mouth). normal hosts and patients with compromised immune function may be treated. 4. vaginal candidiasis, acute or recurrent. 5. prevention of fungal infection in immunocompromised patients considered at risk as a consequence of hiv infections or neutropenia following cytoxic chemotherapy, radiotherapy or bone marrow transplant. 6. ozole 50 mg and 150 mg capsules are also indicated for the treatment of dermatomycoses including tinea pedis, tinea corporis, tinea cruris, pityriasis versicolor & candidiasis.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - aciclovir 400mg;   - dispersible tablet - 400 mg - active: aciclovir 400mg   excipient: colloidal silicon dioxide magnesium stearate microcrystalline cellulose pregelatinised maize starch purified water sodium starch glycolate - · treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. · suppression (prevention of recurrences) of recurrent herpes simplex infections in immune-competent patients. · prophylaxis of herpes simplex infections in immune-competent patients. · treatment of acute herpes zoster (shingles) infections, for the reduction of the duration and severity of acute symptoms and rash, for the reduction of all zoster associated pain and for the reduction of the incidence and duration of postherpetic neuralgia. · management of patients with severe aids who have a cd4 count of less than 50/µl. studies have shown that oral aciclovir given in conjunction with antiretroviral therapy reduced mortality in patients with advanced hiv disease. · patients undergoing allogenic bone marrow transplantation who are at risk of developing cmv infection while immunosuppressed (preceded by one month's treatment with intravenous aciclovir). studies have shown that oral aciclovir reduced mortality in allogenic bone marrow transplant recipients. in addition oral aciclovir provided effective prophylaxis for herpes virus disease.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - naproxen 250mg;  ;   - tablet - 250 mg - active: naproxen 250mg     excipient: lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate sunset yellow fcf

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - naproxen 500mg;  ;   - tablet - 500 mg - active: naproxen 500mg     excipient: lactose monohydrate magnesium stearate maize starch povidone quinoline yellow sodium starch glycolate sunset yellow fcf

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - nitrazepam 5mg;   - tablet - 5 mg - active: nitrazepam 5mg   excipient: lactose monohydrate magnesium stearate maize starch - nitrazepam is indicated in adults for: · short term treatment of insomnia when it is severe, disabling or subjecting the individual to unacceptable distress, where daytime insomnia is acceptable.

Nya Zeeland - engelska - Medsafe (Medicines Safety Authority)

douglas pharmaceuticals limited - amlodipine besilate 13.868mg equivalent to amlodipine 10 mg - tablet - 10 mg - active: amlodipine besilate 13.868mg equivalent to amlodipine 10 mg excipient: colloidal silicon dioxide magnesium stearate mannitol microcrystalline cellulose sodium starch glycolate - indicated for the first line treatment of hypertension and can be used as the sole agent to control blood pressure in the majority of patients. patients not adequately controlled on a single antihypertensive agent may benefit from the addition of ozlodip, which has been used in combination with a thiazide diuretic, beta adrenoceptor blocking agent, or an angiotensinconverting enzyme inhibitor.